Why Is Ekso Bionics (EKSO) Stock Down 15% Today?

Ekso Bionics CEO Scott Davis said the following in the Q2 earnings report. The bad news for Ekso Bionics starts with its diluted earnings per share of -13 cents. That's worse than the -11 cents per share Wall Street was expecting. Even if it's an improvement over the company's -31 cents per share from the same period of the year prior. "With the Medicare reimbursement mechanisms in place, we are focused on reaching a larger U.S. population of individuals living with a spinal cord injury ("SCI") and anticipa ...